From e2fc32ed98550e140beb74381060807c895fa1c1 Mon Sep 17 00:00:00 2001 From: FMS Date: Thu, 4 Apr 2024 16:51:17 +0200 Subject: [PATCH] Auto saved by Logseq --- journals/2024_04_04.md | 1 + 1 file changed, 1 insertion(+) diff --git a/journals/2024_04_04.md b/journals/2024_04_04.md index 557cd322..9692e74b 100644 --- a/journals/2024_04_04.md +++ b/journals/2024_04_04.md @@ -71,6 +71,7 @@ - PL: The work being done by Sanger is it full genome analysis? - AK: sí. su approach también es ese para este proyecto. - JOHN AMUASI: really a rich presentation of the clinical data. Quite a significant variation in the AE. + - AK: We did find larger number of individuals with AE. it was expected. All mild and moderate severity, all self limiting. Non of the participants in the FDC3 had to stop and not take all the doses. - - - ## Cosas de gastos del [[Evento]]